At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

Many companies just iterate indefinitely without ever making progress toward an actual drug,” said one biotech VC on a panel ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side ...